Article

Cell Therapy in Parkinson’s Disease

2013-10-23

Abstract excerpt

: Context: Parkinson's disease (PD) is one of the common neurodegenerative disorders, characterized by the gradual loss of dopamine (DA) containing neurons in the substantia nigra. It is currently treated by L-DOPA and DAergic drugs. Although these treatments are very effective in the beginning of the disease, but they are not curative and have side effects in chronic use. Evidence Acquisitions: The aim of cell re...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1569ead3-4bd8-5308-ab19-2354d095768d
DOI: 10.5812/archneurosci.10279

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cell Therapy in Parkinson’s DiseaseDOI 10.5812/archneurosci.10279Read

Therapy With Mesenchymal Stem Cells in Parkinson DiseaseSemantic proximity Read

Parkinson's Disease and Mesenchymal Stem Cells: Potential for Cell-Based TherapySemantic proximity Read

Towards stem cell based therapies for Parkinson's diseaseSemantic proximity Read

Stem cell‐based therapy for Parkinson's diseaseSemantic proximity Read

Stem cell therapies for Parkinson’s diseaseSemantic proximity Read

Stem-Cell-Based Strategies for the Treatment of Parkinson’s DiseaseSemantic proximity Read

Treatment of Parkinson's disease using cell transplantationSemantic proximity Read

Developing Stem Cell Therapies for Parkinson’s Disease: Waiting Until the Time Is RightSemantic proximity Read

Induced pluripotent stem cells and Parkinson's disease: modelling and treatmentSemantic proximity Read

Cell reprogramming therapy for Parkinson’s diseaseSemantic proximity Read

Stem cell therapy for Parkinson’s disease: safety and modelingSemantic proximity Read

Stem cell-based therapy for Parkinson's disease with a focus on human endometrium-derived mesenchymal stem cells.Semantic proximity Read